OR51E1 and neuroendocrine carcinoma: OR51E1 and OMP were strongly expressed in the SI-NET cell line GOT1 and in the SI-NEC (neuroendocrine carcinoma) cell line P-STS and weakly expressed in the breast cancer cell line MCF10A (Fig. 3).